Inhalation therapy as a mode of home remedial treatment of COVID-19 in Bangladesh
MD. Shakil Ahmed, Rabeya Basri, Mt. Miratun Montaha, Mohammed Rahmatullah
COVID-19 (for coronavirus disease 2019) is the name given to the current pandemic sweeping the world and which started in Wuhan, China at the tail end of December 2019. The causative agent for the disease is SARS-CoV-2 or Severe Acute Respiratory Syndrome Coronavirus 2. As of April 2, 2022 the virus has caused a total of 490,432,789 infected cases throughout the world, which has resulted in 6,172,729 deaths worldwide. The corresponding statistics for Bangladesh are 1,951,714 and 29,122, respectively, which translates to 11,648 cases per million population. Although the world average is 62,918 cases per million population, most rural Bangladesh people suffer from an adequate access to Intensive Care Units, or even hospitals, drugs and vaccines because of a combination of illiteracy, lack of finances for proper treatment, and inadequate access to modern treatment centers. As a result, the people residing mostly outside the capital city Dhaka, have resorted to various home remedial treatments for COVID-19, some of which appear to be surprisingly effective as symptomatic treatments of the disease. The objective of the present study was to document the various forms of inhalation therapy practiced by COVID-19 patients in four districts of Bangladesh and further evaluate the pharmacological significance of this type of therapy.
MD. Shakil Ahmed, Rabeya Basri, Mt. Miratun Montaha, Mohammed Rahmatullah. Inhalation therapy as a mode of home remedial treatment of COVID-19 in Bangladesh. J Med Plants Stud 2022;10(2):45-48. DOI: 10.22271/plants.2022.v10.i2a.1390